U.S.A approves a reagent for the early diagnosis of Alzheimer’s

The Medical Products Agency of USA (FDA) has approved a reagent that can help to identify Alzheimer’s disease in the early stages. The radioactive product called flobetapir is designed to capture the characteristics of the disease, which would be visible by PET (positron...